The ongoing Uber sexual assault litigation spans both federal law and California state court, with a consolidated Uber MDL (multi-district litigation) currently pending in the Northern District of California
Seek emergency medical attention (call 999 or go to A&E) if you experience: Chest pain or difficulty breathing Severe allergic reaction (anaphylaxis), including swelling of the face, lips, or throat Loss of consciousness or collapse Sudden, severe abdominal pain For patients who have sourced retatrutide outside of a clinical trial which is strongly discouraged it is particularly important to inform your GP or a pharmacist, as there is no licensed prescribing information to guide safe use, and the risk of dosing errors or contaminated products is significant
By this point, most users have developed a rough sense of whether their symptoms are manageable or problematic
Here is a summary of the data for Alabama: Medicaid spending on GLP-1s (past 12 months): $43,100,970 Medicaid spending on GLP-1s (YoY change): +107% Medicaid spending on GLP-1s per enrollee (past 12 months): $55 Total Medicaid enrollment: 787,325 Wegovy coverage (obesity-indicated): Yes Zepbound coverage (obesity-indicated): No Saxenda coverage (obesity-indicated): No Ozempic coverage (Type 2 diabetes-indicated): Yes Mounjaro coverage (Type 2 diabetes-indicated): Yes Rybelsus coverage (Type 2 diabetes-indicated): Yes For reference, here are the statistics for the entire United States: Medicaid spending on GLP-1s (past 12 months): $3,452,602,033 Medicaid spending on GLP-1s (YoY change): +142% Medicaid spending on GLP-1s per enrollee (past 12 months): $48 Total Medicaid enrollment: 72,429,055 Wegovy coverage (obesity-indicated): 34 states Zepbound coverage (obesity-indicated): 16 states Saxenda coverage (obesity-indicated): 19 states Ozempic coverage (Type 2 diabetes-indicated): 51 states* Mounjaro coverage (Type 2 diabetes-indicated): 46 states* Rybelsus coverage (Type 2 diabetes-indicated): 46 states *Including District of Columbia For more information, a detailed methodology, and complete results, see Which State Medicaid Programs Cover GLP-1s for Weight Loss & How Much Are They Spending
